
According to the Zhitong Finance App, Fosun International (00656) announced interim results for the six months ended June 30, 2026. The group achieved total revenue of RMB 86.963 billion (same unit), a year-on-year decrease of 0.37%; profit attributable to shareholders of the parent company was RMB 1,721 billion, an increase of 160.3%; and profit per share was 0.21 yuan.
In the first half of 2026, global geopolitical conflicts continued to intensify, and the global economic landscape and inflation expectations became more uncertain. The Group firmly implements the strategy of “focus on core, weight loss and fitness”, and uses innovation and globalization as dual engines to deeply cultivate core businesses such as medical care, consumption, and insurance, and promote both quality and efficiency improvements in industrial operations. Following the completion of non-cash impairment of related assets in fiscal year 2025, the Group's financial base was further consolidated. During the reporting period, driven by the excellent operating performance of the core business, the Group's shareholders' profit attributable to the parent company increased sharply by 160.3% year-on-year to 1.72 billion yuan. During the reporting period, the Group's revenue in the health, insurance and intelligent manufacturing sectors all achieved year-on-year growth. At the same time, the Group continues to promote the disposal of non-core assets, and some subsidiaries are no longer included in the scope of consolidated statements; as of the end of the reporting period, the Group's total revenue was 86.96 billion yuan, which is basically the same as the same period last year.
The Group's asset base remained stable during the reporting period. In order of revenue scale, the top four subsidiaries and business segments are: Fosun Pharmaceuticals, Yuyuan Co., Ltd., Fosun Portugal Insurance, and Fosun Travel. The total revenue reached 63.88 billion yuan, accounting for 73.5% of the Group's total revenue, which remained stable. Globalization is the core strategy that the Group has been adhering to for a long time. Overseas revenue continues to grow, fully verifying the effectiveness of the international layout. During the reporting period, the Group's overseas revenue reached 49.16 billion yuan, accounting for an increase of 3 percentage points to 56.5% over the same period last year.
In the first half of 2026, the Group's core industry operations were steady and improving: among them, the operating profit of the insurance sector grew strongly, with a year-on-year increase of 40%; the profit improvement of Yuyuan Co., Ltd. achieved remarkable results, and net profit attributable to shareholders of the parent company increased 157% year on year. During the reporting period, the Group's industrial operating profit increased 17% year on year, reaching 3.69 billion yuan.